NEW YORK, July 23, 2024 -- The Kinetix Group-Powered by Petauri™ (TKG) has been named a Market Access Agency of the Year finalist in the 2024 MM+M Awards. The MM+M Awards recognizes, champions and celebrates creativity and effectiveness in healthcare marketing and communications. "We have an incredible team at TKG who is truly passionate about empowering informed decision-making and access to patient care...
Rapidly growing pharmaceutical services platform continues to expand team with experienced business development executive NASHVILLE, Tenn. (July 9, 2024) — Petauri, a leading purpose-built pharmaceutical services platform, announced the appointment of Hunter Clark to its business development team. In his role, Hunter will collaborate with Petauri’s growing team of commercialization experts to identify and secure new client partnerships across the biopharmaceutical services space.
Rapidly growing pharmaceutical services platform announces transformational expansion, acquiring two leading businesses focused on evidence-based value demonstration and global market access NASHVILLE, Tenn. (June 18, 2024) — Petauri, a leading purpose-built pharmaceutical services platform, announced today the addition of two UK-based firms: Mtech Access, a premier full-service global market access solutions provider; and Delta Hat, an experience-led company specializing in the technical aspects of evidence-based value demonstration...
Rapidly growing pharmaceutical services platform announces the addition of accomplished executives devoted exclusively to innovative approaches to evidence generation and strategy NASHVILLE, Tenn. (May 2, 2024) — Petauri, a leading purpose-built pharmaceutical services platform, announced today the addition of Nicole Lodowski and Bob Nordyke to lead a team dedicated to evidence generation and value strategy across the product lifecycle, from early pipeline evidence planning through post-launch evidence generation.
Rapidly growing pharmaceutical services platform continues to expand leadership team with highly experienced market access executives NASHVILLE, Tenn. (April 29, 2024) — Petauri Advisors, a strategic life sciences consulting business unit of Petauri, a leading purpose-built pharmaceutical services platform, announced today that it has added to its executive ranks 2 experienced leaders who bring extensive market access experience and expertise comprising implementation of Medicare Part D, the Affordable Care Act, and brand marketing.
Rapidly growing pharmaceutical services platform continues to expand leadership team with highly experienced market access executive NASHVILLE, Tenn. (April 2, 2024) — Petauri, a leading purpose-built pharmaceutical services platform, announced today that Dan Vanderpoel has joined the company in the dual role of Executive Vice President, Strategic Payer Marketing, and Head, Client Solutions.
MM+M has announced its 2024 Pinnacle Awards honorees, who hail from a diverse range of health- and wellness-adjacent organizations. NASHVILLE, Tenn. (February 29, 2024) — Petauri is proud to announce that Dan Renick, CEO of Petauri, has been named as one of the esteemed honorees of the MM+M Pinnacle Awards 2024. This prestigious accolade recognizes exceptional marketers, strategists, and creators for their leadership, innovation, and contributions to the industry.
This prestigious recognition for FORCE Communications––Powered by Petauri™ underscores the company's commitment to fostering a positive and rewarding work environment for its employees.
NASHVILLE, Tenn. (February 27, 2024) — FORCE Communications, a leading provider of innovative medical communication solutions, is proud to announce its recent accolade as one of the Best Places to Work in Indiana. This prestigious recognition underscores the company's commitment to fostering a positive and rewarding work environment for its employees.
NASHVILLE, Tenn. (February 14, 2024) — Petauri, a purpose-built pharmaceutical services platform, announced its acquisition of FORCE Communications and its 3 independent companies, DRIVE, MOMENTUM, and PROPEL, which bring science to life on behalf of clients and their medical innovations.
